價(jià)格 | ¥363 | ¥532 | ¥877 |
包裝 | 1mg | 2mg | 5mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 XMD16-5 | 英文名稱:XMD16-5 |
CAS:1345098-78-3 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.6% | 產(chǎn)品類(lèi)別: 抑制劑 |
貨號(hào): T3710 |
名稱 | XMD16-5 |
描述 | XMD16-5 is a TNK2 inhibitor. TNK2 genomic amplification has been associated with late-stage or metastatic lung and prostate Ys. Overexpression of TNK2 promoted metastasis in a mouse model of breast Y. TNK2 signaling is disrupted in breast, prostate and gastrointestinal tumors. |
細(xì)胞實(shí)驗(yàn) | 293T cells expressing TNK2 are plated in 6-well format at a density of 250,000 cells per well 48 hours prior to treatment. Cells are then treated with a 100 μL of XMD8-87 or XMD16-5 at 5 μmol/L and with 9 1:1 serial dilutions down to ≈10 nmol/L. Two additional samples are treated with DMSO only. Cells are then incubated for 6 hours at 37°C. Protein extraction is accomplished by adding 300 μL of lysis buffer to cells after removing media. Plates are gently shaken for 5 minutes at room temperature. Lysates are collected and cleared of incompletely solubilized material by spinning for 10 minutes at maximum speed in a microcentrifuge. Samples are prepared for SDS-PAGE using the EPage loading buffer.(Only for Reference) |
激酶實(shí)驗(yàn) | Kinase targets are tested with biochemical enzymatic kinase assays using the SelectScreen Kinase Profiling Service to determine IC50 values. The compounds (XMD16-5) are assayed at 10 concentrations (3-fold serial dilutions starting from 1 μM) at an ATP concentration equal to the ATP Km[1]. |
體外活性 | XMD16-5在抑制TNK2磷酸化方面表現(xiàn)出強(qiáng)效。XMD8-87與XMD16-5能強(qiáng)力抑制在實(shí)體瘤類(lèi)型中發(fā)現(xiàn)的TNK2截?cái)嗤蛔兊牧姿峄?/td> |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 45 mg/mL (108.05 mM), Sonication is recommended. H2O : < 1 mg/mL (insoluble or slightly soluble) Ethanol : 5 mg/mL (12.01 mM) |
關(guān)鍵字 | XMD16-5 | inhibit | Tyrosinase | XMD-16-5 | XMD16 5 | Inhibitor | XMD165 |
相關(guān)產(chǎn)品 | Oxyresveratrol | Icariin | Daidzein | PHYTOL | 5-Aminosalicylic Acid | Fenofibrate | 2,3-Butanediol | Naringenin | 2-Ketoglutaric acid | Kojic acid | Methyl cinnamate | Hexylresorcinol |
相關(guān)庫(kù) | 抑制劑庫(kù) | 經(jīng)典已知活性庫(kù) | 已知活性化合物庫(kù) | 轉(zhuǎn)錄因子庫(kù) | 激酶抑制劑庫(kù) | 抗衰老化合物庫(kù) | 蛋白酶抑制劑庫(kù) | 糖代謝化合物庫(kù) | 酪氨酸激酶分子庫(kù) | 抗代謝疾病化合物庫(kù) |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-01-20 | |
詢價(jià) |
VIP2年
|
德陽(yáng)思諾生物科技有限公司
|
2025-01-07 | |
¥2492.90 |
VIP2年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 |